SONN, a US stock, rose more than 270% before the market opened, and announced that it would establish a "HYPE version of MicroStrategy" to hold 12.6 million HYPE and $300 million in cash

This article is machine translated
Show original

On July 14, the stock price of the US-listed company Sonnet BioTherapeutics Holdings, Inc. (SONN) rose 273.11% before market opening, with a pre-market trading price of $19.29, an increase of $14.05 from the previous trading price.

BlockBeats previously reported that the US-listed company Sonnet will merge to form Hyperliquid Strategies and launch a treasury strategy, holding 12.6 million HYPE tokens and $300 million in cash.

Source
Disclaimer: The content above is only the author's opinion which does not represent any position of Followin, and is not intended as, and shall not be understood or construed as, investment advice from Followin.
Like
Add to Favorites
Comments